High Dose Chemotherapy and Peripheral Blood Progenitor Cell Rescue for Patients With Breast Cancer


Phase 2
18 Years
65 Years
Open (Enrolling)
Both
Graft vs Host Disease

Thank you

Trial Information

High Dose Chemotherapy and Peripheral Blood Progenitor Cell Rescue for Patients With Breast Cancer


Inclusion Criteria:



- Stage II, III or IV breast cancer

- chemosensitive

- adequate organ function

Exclusion Criteria:

- prior transplant,

- life threatening disease

- brain metastases

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Survival

Principal Investigator

Ginna Laport, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Stanford University

Authority:

United States: Food and Drug Administration

Study ID:

BMT42

NCT ID:

NCT00186641

Start Date:

Completion Date:

March 2005

Related Keywords:

  • Graft Vs Host Disease
  • chronic Graft vs Host Disease
  • Breast Neoplasms
  • Graft vs Host Disease

Name

Location
Stanford University Cancer Center Stanford, California  94305